838 related articles for article (PubMed ID: 28970148)
1. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
Rich NE; Oji S; Mufti AR; Browning JD; Parikh ND; Odewole M; Mayo H; Singal AG
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):198-210.e2. PubMed ID: 28970148
[TBL] [Abstract][Full Text] [Related]
2. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis.
Balakrishnan M; Patel P; Dunn-Valadez S; Dao C; Khan V; Ali H; El-Serag L; Hernaez R; Sisson A; Thrift AP; Liu Y; El-Serag HB; Kanwal F
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):61-71.e15. PubMed ID: 32360810
[TBL] [Abstract][Full Text] [Related]
3. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Taylor RS; Taylor RJ; Bayliss S; Hagström H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wai-Sun Wong V; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN
Gastroenterology; 2020 May; 158(6):1611-1625.e12. PubMed ID: 32027911
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
5. Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort.
El Khoudary SR; Samargandy S; Zeb I; Foster T; de Boer IH; Li D; Budoff MJ
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):114-122. PubMed ID: 31761548
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; McNeil R; Turner MJ; Han B; Provenzale D; Choi SS; Moylan CA; Hunt CM
Aliment Pharmacol Ther; 2018 Jan; 47(2):268-278. PubMed ID: 29115682
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.
Loomba R; Wong R; Fraysse J; Shreay S; Li S; Harrison S; Gordon SC
Aliment Pharmacol Ther; 2020 Jun; 51(11):1149-1159. PubMed ID: 32372515
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection.
Maurice JB; Patel A; Scott AJ; Patel K; Thursz M; Lemoine M
AIDS; 2017 Jul; 31(11):1621-1632. PubMed ID: 28398960
[TBL] [Abstract][Full Text] [Related]
10. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis.
Patel P; Muller C; Paul S
World J Hepatol; 2020 Aug; 12(8):506-518. PubMed ID: 32952877
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysis.
Kalligeros M; Vassilopoulos A; Shehadeh F; Vassilopoulos S; Lazaridou I; Mylonakis E; Promrat K; Wands JR
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1708-1722. PubMed ID: 36642292
[TBL] [Abstract][Full Text] [Related]
13. Ethnicity and nonalcoholic fatty liver disease.
Bambha K; Belt P; Abraham M; Wilson LA; Pabst M; Ferrell L; Unalp-Arida A; Bass N;
Hepatology; 2012 Mar; 55(3):769-80. PubMed ID: 21987488
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.
Setiawan VW; Stram DO; Porcel J; Lu SC; Le Marchand L; Noureddin M
Hepatology; 2016 Dec; 64(6):1969-1977. PubMed ID: 27301913
[TBL] [Abstract][Full Text] [Related]
15. Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016.
Le MH; Yeo YH; Cheung R; Wong VW; Nguyen MH
J Intern Med; 2020 Jun; 287(6):711-722. PubMed ID: 32128904
[TBL] [Abstract][Full Text] [Related]
16. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
17. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic Fatty Liver Disease in Latinos.
Saab S; Manne V; Nieto J; Schwimmer JB; Chalasani NP
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):5-12; quiz e9-10. PubMed ID: 25976180
[TBL] [Abstract][Full Text] [Related]
19. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study.
Jaruvongvanich V; Wijarnpreecha K; Ungprasert P
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):629-634. PubMed ID: 28716600
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.
Harrison SA; Gawrieh S; Roberts K; Lisanti CJ; Schwope RB; Cebe KM; Paradis V; Bedossa P; Aldridge Whitehead JM; Labourdette A; Miette V; Neubauer S; Fournier C; Paredes AH; Alkhouri N
J Hepatol; 2021 Aug; 75(2):284-291. PubMed ID: 33746083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]